BIOMAT Database Logo BIOMAT Database Logo

Non-suppressible insulin-like activity in Laron's syndrome. 1979

K W Kastrup, and J Zapf

Severe growth retardation is found in patients with high levels of growth hormone and low sulphation factor activity or somatomedin. Also non-suppressible insulin-like activity (NSILA-s) has been found to be very low in a patient with this condition as measured by bioassay, protein binding assay and radioimmunoassay and to be below activities found in hypopituitary patients. Partially purified NSILA-s restored the ability of serum to increase sulphation activity although full restitution may still depend on other factors. These findings support the hypothesis that NSILA-s belongs to the family of somatomedin and thus is involved in promoting growth, and that low activity of these growth factors is a primary cause of the growth retardation found in these patients.

UI MeSH Term Description Entries
D008297 Male Males
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009632 Nonsuppressible Insulin-Like Activity A blood protein (NSILA) which mimics the biological activity of insulin in serum, but is not suppressed by insulin antibodies. During acid-ethanol extraction of Cohn fraction III, 10% of the activity is found in the supernatant (NSILA-S) and the remaining activity in the precipitate (NSILA-P). The latter is a large molecular compound, much less stable than the soluble fraction. NSILA-S is a more potent growth factor than insulin and exhibits sulfation activity. NSILA,NSILA-P,NSILA-S,Nonsuppressible Insulinlike Activity,Activity, Nonsuppressible Insulin-Like,Activity, Nonsuppressible Insulinlike,Insulin-Like Activity, Nonsuppressible,Insulinlike Activity, Nonsuppressible,Nonsuppressible Insulin Like Activity
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002356 Cartilage A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE. Cartilages
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002850 Chromatography, Gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination. Chromatography, Exclusion,Chromatography, Gel Permeation,Chromatography, Molecular Sieve,Gel Filtration,Gel Filtration Chromatography,Chromatography, Size Exclusion,Exclusion Chromatography,Gel Chromatography,Gel Permeation Chromatography,Molecular Sieve Chromatography,Chromatography, Gel Filtration,Exclusion Chromatography, Size,Filtration Chromatography, Gel,Filtration, Gel,Sieve Chromatography, Molecular,Size Exclusion Chromatography
D006130 Growth Disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Stunted Growth,Stunting,Disorder, Growth,Growth Disorder,Growth, Stunted,Stuntings

Related Publications

K W Kastrup, and J Zapf
Radioimmunoassay for non-suppressible insulin-like activity.
January 1976, Hormone research,
K W Kastrup, and J Zapf
Non-suppressible insulin-like activity of human serum. II. Biological properties of plasma extracts with non-suppressible insulin-like activity.
June 1966, Biochimica et biophysica acta,
K W Kastrup, and J Zapf
[Physiological significance of NSILA (non-suppressible insulin-like activity)].
March 1969, Saishin igaku. Modern medicine,
K W Kastrup, and J Zapf
Deficiency of non-suppressible insulin-like activity in thalassaemia major.
November 1981, Archives of disease in childhood,
K W Kastrup, and J Zapf
Insulin-like growth factor characteristics of an acidic non-suppressible insulin-like activity.
October 1984, The Biochemical journal,
K W Kastrup, and J Zapf
Assay of insulin-like activity by the isolated fat cell method. II. The suppressible and non-suppressible insulin-like activity of serum.
August 1967, Diabetologia,
K W Kastrup, and J Zapf
Non-suppressible insulin-like activity during pregnancy in women with diabetes mellitus.
August 1981, Clinical endocrinology,
K W Kastrup, and J Zapf
[INSULIN ACTIVITY IN THE HUMAN SERUM SUPPRESSIBLE AND NON-SUPPRESSIBLE WITH ANTI-INSULIN SERUM].
February 1964, Schweizerische medizinische Wochenschrift,
K W Kastrup, and J Zapf
Decrease of non-suppressible insulin-like activity after pancreatectomy and normalization by insulin therapy.
August 1977, Acta endocrinologica,
K W Kastrup, and J Zapf
Non-suppressible insulin-like activity in relation to liver function and to disease.
June 1970, Panminerva medica,
Copied contents to your clipboard!